News Listing

December 22, 2016

The Georgia Institute of Technology will play a key role in a new federally backed initiative to advance medications made from cells, such as vaccines...

Doctors knew long before Owen Webb was born that they were racing against the clock to save his life.

Tests had confirmed the developing child suffered from Krabbe disease, a genetic...

In this age of rapidly changing technology and global challenges, the question has become, “What’s next...

Krishnendu Roy scanned the room, taking note of the people all around him in the Vatican, and thought, “what the heck am I doing here?”

There was Bill Frist, former majority leader of the U....

An industry-driven consortium has developed a national roadmap designed to chart the path to large-scale manufacturing of cell-based therapeutics for use in a broad range of illnesses including...

A $15.7 million grant from the Atlanta-based Marcus Foundation has helped launch a new Georgia Institute of Technology research center that will develop processes and techniques for ensuring the...

In The News

Georgia Research Alliance and Georgia Tech sources also provided funding for a total investment of $23 million. The center also plans to seek funding from federal agencies, clinical research organizations and other sources.
In a step that could lead to a new diabetes treatment, several Boston-area hospitals have teamed up with the Harvard Stem Cell Institute and biotech Semma Therapeutics to make personalized cell-based therapies and organize clinical trials.
The work of the new Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M) is expected to provide standardized production and quality testing of these living cells, similar to that which already exists for drug-based pharmaceuticals.
A $15.7 million grant from the Atlanta-based Marcus Foundation has helped launch a new Georgia Institute of Technology research center that will develop processes and techniques for ensuring the consistent, low-cost, large-scale manufacture of high-qualit
Consortium develops national roadmap for advanced cell manufacturing, showing the way to cell-based therapeutics.
Georgia Tech, GRA and industry partners charting a path to large-scale manufacturing of cell-based therapeutics.